United States Non–Invasive Prenatal Testing Market 2019 – 2026
SKU ID : DPI-14816315 | Publishing Date : 25-Jul-2019 | No. of pages : 120
Detailed TOC of United States Non–Invasive Prenatal Testing Market 2019 – 2026
1. Executive Summary2. United States Non–Invasive Prenatal Testing(NIPT) Market Size & Analysis (2015 – 2026)
2.1 Total Actual NIPT Test Volume (Number of Tests Performed) & Forecast (2015 – 2026)
2.1.1 Average Risk Actual NIPT Test Volume (Number of Tests Performed) & Forecast (2015 – 2026)
2.1.2 High–Risk Actual NIPT Test Volume (Number of Tests Performed) & Forecast (2015 – 2026)
2.2 Total Actual NIPT Test Market Revenue & Forecast (2015 – 2026)
2.2.1 Average Risk Actual NIPT Test Market Revenue & Forecast (2015 – 2026)
2.2.2 High–Risk Actual NIPT Test Market Revenue & Forecast (2015 – 2026)
3. United States Non–Invasive Prenatal Testing(NIPT) Market Opportunity Assessment (2015 – 2026)
3.1 Total Potential NIPT Test Volume (Number of Tests Performed) & Forecast (2015 – 2026)
3.1.1 Average Risk Potential NIPT Test Volume (Number of Tests Performed) & Forecast (2015 – 2026)
3.1.2 High–Risk Potential NIPT Test Volume (Number of Tests Performed) & Forecast (2015 – 2026)
3.2 Total Potential NIPT Test Market Revenue & Forecast (2015 – 2026)
3.2.1 Average Risk Potential NIPT Test Market Revenue & Forecast (2015 – 2026)
3.2.2 High–Risk Potential NIPT Test Market Revenue & Forecast (2015 – 2026)
4. United States Non–Invasive Prenatal Testing Market Drivers and Inhibitors
4.1 Market Drivers
4.2 Market Inhibitors
5. Non–Invasive Prenatal Testing Comparative Analysis – By Test
6. Reimbursement Policies of the United States Non–Invasive Prenatal Testing
7. Regulation System of the United States Non–Invasive Prenatal Testing
8. Major Deals in the Non–Invasive Prenatal Testing Market
8.1 Collaboration Deals
8.2 Venture Capital Investment
8.3 Merger and Acquisition
8.4 Exclusive Agreement
8.5 Licensing Agreement
8.6 Distribution Agreement
8.7 Partnership Deals
9. Key Companies Analysis
9.1 Integrated Genetics (LabCorp)
9.1.1 Business Overview
9.1.2 Product Outlook
9.1.3 Key Developments
9.2 Ariosa Diagnostics (Roche)
9.2.1 Business Overview
9.2.2 Product Outlook
9.2.3 Key Developments
9.3 Illumina
9.3.1 Business Overview
9.3.2 Product Outlook
9.3.3 Key Developments
9.4 Natera
9.4.1 Business Overview
9.4.2 Product Outlook
9.4.3 Key Developments
9.5 Quest Diagnostics
9.5.1 Business Overview
9.5.2 Product Outlook
9.5.3 Key Developments
9.6 Myriad Genetics
9.6.1 Business Overview
9.6.2 Product Outlook
9.6.3 Key Developments
9.7 Centogene
9.7.1 Business Overview
9.7.2 Product Outlook
9.7.3 Key Developments
9.8 Invitae Corporation
9.8.1 Business Overview
9.8.2 Product Outlook
9.8.3 Key Developments
9.9 Otogenetics
9.9.1 Business Overview
9.9.2 Product Outlook
9.9.3 Key Developments
9.10 GenPath
9.10.1 Business Overview
9.10.2 Product Outlook
9.10.3 Key Developments
9.11 Progenity
9.11.1 Business Overview
9.11.2 Product Outlook
9.11.3 Key Developments
9.12 PerkinElmer
9.12.1 Business Overview
9.12.2 Product Outlook
9.12.3 Key Developments
9.13 Agilent Technologies
9.13.1 Business Overview
9.13.2 Product Outlook
9.13.3 Key Developments
List of Figures, Tables and Charts Available in United States Non–Invasive Prenatal Testing Market 2019 – 2026
List of TablesTable 4–1: Maternal Age at Delivery and Risk of Down Syndrome
Table 5–1: Non–Invasive Prenatal Testing – Comparative Tests Analysis
Table 6–1: NIPT Test CMS Price (US$),2017
Table 7–1: Collaboration Deals in the Non–Invasive Prenatal Testing Market
Table 7–2: Venture Capital Investment in the Non–Invasive Prenatal Testing Market
Table 7–3: Merger & Acquisition in the Non–Invasive Prenatal Testing Market
Table 7–4: Exclusive Agreement in the Non–Invasive Prenatal Testing Market
Table 7–5: Licensing Agreement in the Non–Invasive Prenatal Testing Market
Table 7–6: Distribution Agreement in the Non–Invasive Prenatal Testing Market
Table 7–7: Partnership Deals in the Non–Invasive Prenatal Testing Market
List of Figures
Figure 2–1: United States Actual NIPT Test Volume (Thousand),2015 – 2018
Figure 2–2: United States Actual NIPT Test Volume Forecast (Thousand),2019 – 2026
Figure 2–3: United States Average Risk Actual NIPT Test Volume (Thousand),2015 – 2018
Figure 2–4: United States Average Risk Actual NIPT Test Volume Forecast (Thousand),2019 – 2025
Figure 2–5: United States High–Risk Actual NIPT Test Volume (Thousand),2015 – 2018
Figure 2–6: United States High–Risk Actual NIPT Test Volume Forecast (Thousand),2019 – 2026
Figure 2–7: United States Actual NIPT Test Market Revenue (Million US$),2015 – 2018
Figure 2–8: United States Actual NIPT Test Market Revenue Forecast (Million US$),2019 – 2026
Figure 2–9: United States Average Risk Actual NIPT Test Market Revenue (Million US$),2015 – 2018
Figure 2–10: United States Average Risk Actual NIPT Test Market Revenue Forecast (Million US$),2019 – 2026
Figure 2–11: United States High–Risk Actual NIPT Test Market Revenue (Million US$),2015 – 2018
Figure 2–12: United States High–Risk Actual NIPT Test Market Revenue Forecast (Million US$),2019 – 2026
Figure 3–1: United States Potential NIPT Test Volume (Thousand),2015 – 2018
Figure 3–2: United States Potential NIPT Test Volume Forecast (Thousand),2019 – 2026
Figure 3–3: United States Average Risk Potential NIPT Test Volume (Thousand),2015 – 2018
Figure 3–4: United States Average Risk Potential NIPT Test Volume Forecast (Thousand),2019 – 2026
Figure 3–5: United States High–Risk Potential NIPT Test Volume (Thousand),2015 – 2018
Figure 3–6: United States High–Risk Potential NIPT Test Volume Forecast (Thousand),2019 – 2026
Figure 3–7: United States Potential NIPT Test Market Revenue (Million US$),2015 – 2018
Figure 3–8: United States Potential NIPT Test Market Revenue Forecast (Million US$),2019 – 2026
Figure 3–9: United States Average Risk Potential NIPT Test Market Revenue (Million US$),2015 – 2018
Figure 3–10: United States Average Risk Potential NIPT Test Market Revenue Forecast (Million US$),2019 – 2026
Figure 3–11: United States High–Risk Potential NIPT Test Market Revenue (Million US$),2015 – 2018
Figure 3–12: United States High–Risk Potential NIPT Test Market Revenue Forecast (Million US$),2019 – 2026